CN104231039A - 用于合成***模拟肽衍生物的功能小分子及其制备方法 - Google Patents
用于合成***模拟肽衍生物的功能小分子及其制备方法 Download PDFInfo
- Publication number
- CN104231039A CN104231039A CN201310229754.XA CN201310229754A CN104231039A CN 104231039 A CN104231039 A CN 104231039A CN 201310229754 A CN201310229754 A CN 201310229754A CN 104231039 A CN104231039 A CN 104231039A
- Authority
- CN
- China
- Prior art keywords
- preparation
- mimetic peptide
- erythropoietin mimetic
- general formula
- erythropoietin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310229754.XA CN104231039A (zh) | 2013-06-08 | 2013-06-08 | 用于合成***模拟肽衍生物的功能小分子及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310229754.XA CN104231039A (zh) | 2013-06-08 | 2013-06-08 | 用于合成***模拟肽衍生物的功能小分子及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104231039A true CN104231039A (zh) | 2014-12-24 |
Family
ID=52220027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310229754.XA Pending CN104231039A (zh) | 2013-06-08 | 2013-06-08 | 用于合成***模拟肽衍生物的功能小分子及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104231039A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085654A (zh) * | 2015-08-26 | 2015-11-25 | 天津药物研究院有限公司 | 一种***模拟肽及其制备方法和应用 |
CN105085653A (zh) * | 2015-08-26 | 2015-11-25 | 天津药物研究院有限公司 | 一种***模拟肽及其制备方法和应用 |
CN105153293A (zh) * | 2015-08-26 | 2015-12-16 | 天津药物研究院有限公司 | 一种***模拟肽及其二聚体、以及制备方法和应用 |
CN109985232A (zh) * | 2017-12-29 | 2019-07-09 | 江苏豪森药业集团有限公司 | 培化西海马肽的药物组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101456911A (zh) * | 2007-12-12 | 2009-06-17 | 江苏豪森药业股份有限公司 | ***模拟肽衍生物及其可药用盐和其制备方法与用途 |
-
2013
- 2013-06-08 CN CN201310229754.XA patent/CN104231039A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101456911A (zh) * | 2007-12-12 | 2009-06-17 | 江苏豪森药业股份有限公司 | ***模拟肽衍生物及其可药用盐和其制备方法与用途 |
Non-Patent Citations (1)
Title |
---|
颜***编: "《蛋白质研究技术》", 31 January 2007, 第四军医大学出版社 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085654A (zh) * | 2015-08-26 | 2015-11-25 | 天津药物研究院有限公司 | 一种***模拟肽及其制备方法和应用 |
CN105085653A (zh) * | 2015-08-26 | 2015-11-25 | 天津药物研究院有限公司 | 一种***模拟肽及其制备方法和应用 |
CN105153293A (zh) * | 2015-08-26 | 2015-12-16 | 天津药物研究院有限公司 | 一种***模拟肽及其二聚体、以及制备方法和应用 |
CN105085653B (zh) * | 2015-08-26 | 2019-01-08 | 天津药物研究院有限公司 | 一种***模拟肽及其制备方法和应用 |
CN105153293B (zh) * | 2015-08-26 | 2019-01-08 | 天津药物研究院有限公司 | 一种***模拟肽及其二聚体、以及制备方法和应用 |
CN105085654B (zh) * | 2015-08-26 | 2019-01-08 | 天津药物研究院有限公司 | 一种***模拟肽及其制备方法和应用 |
CN109985232A (zh) * | 2017-12-29 | 2019-07-09 | 江苏豪森药业集团有限公司 | 培化西海马肽的药物组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6034802B2 (ja) | 大環状ラクタムの調製のための方法および中間体 | |
CN105143183A (zh) | 联芳基取代的4-氨基丁酸衍生物及其制备方法和用途 | |
CN104370862B (zh) | 水溶性抗肿瘤化合物 | |
CN104231039A (zh) | 用于合成***模拟肽衍生物的功能小分子及其制备方法 | |
KR20110025731A (ko) | 에리트로포이에틴 모방 펩티드 유도체 및 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이의 용도 | |
CN107903389B (zh) | E选择素靶向的聚乙二醇两端双修饰抗肿瘤药物的合成及应用 | |
CN112592331B (zh) | 一种奥司他韦protac化合物及其制备方法与在抗流感病毒药物中的应用 | |
US7666906B2 (en) | β-Benzyloxyaspartate derivatives with amino group on benzene ring | |
CN101910128B (zh) | 二醇二氮烯*化合物、其制备方法以及含有它们的药用组合物 | |
CN1951936A (zh) | 一种阿加曲班的分离方法 | |
CN109071607A (zh) | 一类万古霉素衍生物、其制备方法、药物组合物和用途 | |
CN113683651A (zh) | 一种GalNAc中间体的制备方法 | |
CN105254569B (zh) | 奥硝唑注射液杂质1‑(3‑氯‑丙烯基)‑2‑甲基‑5‑硝基咪唑的制备方法 | |
WO2022017317A1 (zh) | 一种规模化合成河豚毒素的方法 | |
CN111285923B (zh) | 一种psd-95抑制剂 | |
EP3950700A1 (en) | Peptide complex and production method therefor, and use of said peptide complex | |
CN109280044B (zh) | 雷替曲塞杂质c及其制备和应用 | |
CN1296360C (zh) | (1r,2r)-或(1s,2s)-1-(4'-取代-1',8'-萘酰亚胺基)-2-氨基环己烷及其制法和用途 | |
CN114524812A (zh) | 1,4-二氢-1,6-萘啶化合物的晶型制备以及合成方法 | |
CN113234052A (zh) | 细胞外调节蛋白激酶抑制剂及其制备方法与应用 | |
KR20120064415A (ko) | 카스포펀진 제조방법 및 그의 신규 중간체 | |
CN105566447A (zh) | 一种凋亡抑制蛋白的类肽拮抗剂及其合成方法与应用 | |
CN104650342B (zh) | 多支链聚合药物前体及其应用 | |
CN104292146A (zh) | 特拉匹韦中间体及其制备方法 | |
CN110903304A (zh) | 一种大田软海绵酸衍生物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address after: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160316 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: Tenth Industrial Zone, Lianyungang, Jiangsu, China, 222047 Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141224 |
|
RJ01 | Rejection of invention patent application after publication |